SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000816284-17-000009
Filing Date
2017-07-27
Accepted
2017-07-27 16:06:27
Documents
89
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2017063010q.htm 10-Q 2248415
2 EXHIBIT 31.1 CERTIFICATION OF THE CEO SECTION 302 ex311certificationoftheceo.htm EX-31.1 10347
3 EXHIBIT 31.2 CERTIFICATION OF THE CFO SECTION 302 ex312certificationofthecfo.htm EX-31.2 11204
4 EXHIBIT 32.1 CERTIFICATION OF THE CEO SECTION 906 ex321certificationoftheceo.htm EX-32.1 6936
5 EXHIBIT 32.2 CERTIFICATION OF THE CFO SECTION 906 ex322certificationofthecfo.htm EX-32.2 8337
  Complete submission text file 0000816284-17-000009.txt   10808365

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT celg-20170630.xml EX-101.INS 2831593
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celg-20170630.xsd EX-101.SCH 57305
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT celg-20170630_cal.xml EX-101.CAL 102895
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celg-20170630_def.xml EX-101.DEF 354026
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celg-20170630_lab.xml EX-101.LAB 785592
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celg-20170630_pre.xml EX-101.PRE 513519
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34912 | Film No.: 17986312
SIC: 2834 Pharmaceutical Preparations